Standout Papers

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study 2010 2026 2015 2020 488
  1. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study (2010)
    David M. Thomas, Robert M. Henshaw et al. The Lancet Oncology

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 60 standout
Sub-graph 1 of 22

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
2023 Standout
4 intermediate papers

Works of Zhishen Ye being referenced

Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time
2013

Author Peers

Author Last Decade Papers Cites
Zhishen Ye 868 457 228 424 20 1.5k
Bernadette Liegl 928 316 512 571 40 2.1k
D. Ian Hodson 1130 839 106 169 37 2.0k
L. H. Weiland 416 633 419 268 44 1.7k
Juan C. Gutierrez 816 752 231 396 31 1.9k
Linda A. Murakata 531 360 170 248 19 1.4k
Tatsuro Fukuya 359 276 189 219 48 1.4k
Frank Vellios 478 443 102 260 51 2.0k
Harvey W. Baker 315 734 181 236 48 2.2k
H. J. Wanebo 906 1062 271 107 33 1.9k
C. G. Diederichs 638 477 150 120 19 1.5k

All Works

Loading papers...

Rankless by CCL
2026